Patients are preselected for CDKN2A and/or CDKN2B abnormalities - - Safety and efficacy data to be reported at an upcoming oncology medical conference - BERKELEY HEIGHTS, N.J., Sept. 25, 2024 (GLOBE ...

During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...

The Securities and Exchange Board of India (SEBI) on Wednesday launched a dedicated Foreign Portfolio Investor (FPI) outreach cell as part of the Alternative Investment Fund and Foreign Portfolio ...

In an interview with Targeted Oncology, Mark R. Litzow, MD, discussed the incorporation of Immunotherapy into upfront acute ...

The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor ... This overexpression contributes to tumor cell proliferation through cell cycle dysregulation, ...

Japan’s MHLF approves Padcev with Keytruda for first-line treatment of radically unresectable urothelial carcinoma: Tokyo Wednesday, September 25, 2024, 11:00 Hrs [IST] Astellas ...

Rather than a ground-up redesign, the 2026 Hyundai Nexo fuel-cell SUV is believed to build on the outgoing model in every respect ...

CS Genetics, an innovative genomics technology company, today announced a strategic partnership with ROSALIND®, the premier SaaS platform empowering life science research across diverse technologies.

Microvast Holdings, Inc. (NASDAQ: MVST) ("Microvast", the "Company", "we" or "our"), a technology innovator that designs, ...

Shanghai Henlius Biotech, Inc. (2696) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending approval of ...

A-B, UMAP plot of all filtered cells after integration coloured by sample type and sorting status (A) and estimated cell cycle phase (B). C, Raincloud plots of normalised expression of BFP. D, ...

In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by ...